Rani Therapeutics | 4:持股变动声明-董事 Nanavaty Maulik
Rani Therapeutics | 4:持股变动声明-董事 IMRAN MIR A
Rani Therapeutics | 4:持股变动声明-董事 Farquharson Andrew
Rani Therapeutics | 4:持股变动声明-董事 DEBUONO LAUREEN
Rani Therapeutics | 4:持股变动声明-董事 Rometty Lisa Ann
Rani Therapeutics | 4:持股变动声明-董事 Ausiello Dennis A
Rani Therapeutics | 4:持股变动声明-董事 BUTEL JEAN LUC
Rani Therapeutics | 4:持股变动声明-高管 McKinley Kate
Rani Therapeutics | 4:持股变动声明-高管 Imran Talat
Rani Therapeutics | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(8.66%),Steven Boyd(8.66%)
Rani Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-South Cone Investments Limited Partnership(28.2%),South Lake One LLC(28.2%)等
Rani Therapeutics | 4:持股变动声明-股东 South Cone Investments Limited Partnership
Rani Therapeutics | 4:持股变动声明-董事 IMRAN MIR A
Rani Therapeutics | 4:持股变动声明-董事 Farquharson Andrew
Rani Therapeutics | 4:持股变动声明-董事 BUTEL JEAN LUC
Rani Therapeutics | 4:持股变动声明-董事 Rometty Lisa Ann
Rani Therapeutics | 4:持股变动声明-董事 Ausiello Dennis A
Rani Therapeutics | 4:持股变动声明-董事 Nanavaty Maulik
Rani Therapeutics | 4:持股变动声明-高管 McKinley Kate
Rani Therapeutics | 4:持股变动声明-高管 Hashim Mir
暂无数据